Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Valsartan 160mg capsules
0205052V0AAACAC
|
Valsartan | Valsartan | Cardiovascular System | 38,285 |
|
Valsartan 80mg capsules
0205052V0AAABAB
|
Valsartan | Valsartan | Cardiovascular System | 35,994 |
|
Valsartan 40mg capsules
0205052V0AAAAAA
|
Valsartan | Valsartan | Cardiovascular System | 18,777 |
|
Valsartan 320mg tablets
0205052V0AAAFAF
|
Valsartan | Valsartan | Cardiovascular System | 5,963 |
|
Valsartan 40mg tablets
0205052V0AAADAD
|
Valsartan | Valsartan | Cardiovascular System | 2,270 |
|
Valsartan 160mg tablets
0205052V0AAAHAH
|
Valsartan | Valsartan | Cardiovascular System | 2,103 |
|
Valsartan 80mg tablets
0205052V0AAAIAI
|
Valsartan | Valsartan | Cardiovascular System | 1,114 |
|
Valsartan 3mg/ml oral solution
0205052V0AAAJAJ
|
Valsartan | Valsartan | Cardiovascular System | 12 |
|
Diovan 3mg/1ml oral solution
0205052V0BBAFAJ
|
Diovan | Valsartan | Cardiovascular System | 3 |
|
Diovan 160mg capsules
0205052V0BBACAC
|
Diovan | Valsartan | Cardiovascular System | No data available |
|
Diovan 320mg tablets
0205052V0BBAEAF
|
Diovan | Valsartan | Cardiovascular System | No data available |
|
Diovan 40mg capsules
0205052V0BBAAAA
|
Diovan | Valsartan | Cardiovascular System | No data available |
|
Diovan 40mg tablets
0205052V0BBADAD
|
Diovan | Valsartan | Cardiovascular System | No data available |
|
Diovan 80mg capsules
0205052V0BBABAB
|
Diovan | Valsartan | Cardiovascular System | No data available |
|
Valsartan 160mg/5ml oral liquid
0205052V0AAAGAG
|
Valsartan | Valsartan | Cardiovascular System | No data available |
|
Valsartan 40mg/5ml oral liquid
0205052V0AAAEAE
|
Valsartan | Valsartan | Cardiovascular System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.